SGLT2 inhibitors have been shown to reduce risk of acute kidney injury, but whether kidney effects are modified by risk of acute dips in eGFR is unknown.

Increased mortality seen in association with longer nap duration, greater intraindividual variability, more naps from 11 a.m. to 1 p.m., 1 to 3 p.m.

Statin use in adults linked to lower 28-day all-cause mortality and with reduced ICU mortality. (HealthDay News) — For critically ill adults with sepsis, statin use is associated with reduced ...

The histopathologic features of eosinophilic angiocentric fibrosis overlap with IgG4-RD and AAV, making diagnosis difficult.

Investigators assessed which aspects of surgical performance during radical prostatectomy improve the chances of good functional outcomes.

GLP-1RA use initially lowered delirium risk but eventually heightened delirium risk after 5 years among patients with type 2 diabetes.

In real-world cohort, percentage weight reduction at one year was 3.6, 6.8, and 11.9 percent with early and late discontinuation and nondiscontinuation, respectively.

(HealthDay News) — From 2013 to 2023, there was an increase in the proportion of U.S. adults who were unaware of having hypertension, according to a research letter published online June 4 in JAMA ...

(HealthDay News) — The artificial sweetener neotame is ubiquitous in popular disposable e-cigarettes, according to a research letter published online June 2 in the Journal of the American Medical ...

(HealthDay News) — Medical school attrition rates are high among lesbian, gay, or bisexual (LGB) medical students, according to a research letter published online June 10 in JAMA Network Open.

Investigators examined the comparative effectiveness of SGLT2 inhibitors and GLP-1 receptor agonists in a real-world setting.

The FDA has accepted the NDA for zoliflodacin for the treatment of uncomplicated gonorrhea in adults and pediatric patients 12 years and older.